Trial intelligence / Profile preview

Esketamine dose-ranging randomized trial for painless colonoscopy

ChiCTR2100047032Phase 4Recruiting

Sponsor
The 2nd Affiliated Hospital of Chongqing Medical University
Start
Jun 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of esketamine and propofol in None (4 arms), sponsored by The 2nd Affiliated Hospital of Chongqing Medical University. Primary endpoints: blood pressure, respiratory rate and 2 more. Started Jun 2021; status: recruiting.

02

Drugs

esketaminepropofol

Beyond the preview

Go deeper on ChiCTR2100047032.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100047032.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call